Kessel, S. P. v., Frye, A. K., El-Gendy, A. O., Castejon, M., Keshavarzian, A., Dijk, G. v., & Aidy, S. E. (2019). Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease. Nature Portfolio.
Chicago Style (17th ed.) CitationKessel, Sebastiaan P. van, Alexandra K. Frye, Ahmed O. El-Gendy, Maria Castejon, Ali Keshavarzian, Gertjan van Dijk, and Sahar El Aidy. Gut Bacterial Tyrosine Decarboxylases Restrict Levels of Levodopa in the Treatment of Parkinson’s Disease. Nature Portfolio, 2019.
MLA (8th ed.) CitationKessel, Sebastiaan P. van, et al. Gut Bacterial Tyrosine Decarboxylases Restrict Levels of Levodopa in the Treatment of Parkinson’s Disease. Nature Portfolio, 2019.
Warning: These citations may not always be 100% accurate.